Related Experiment Videos
A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus
G R Rosania1, J Merlie, N Gray
1Department of Chemistry and Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USA.
Abstract:
Cellular differentiation is a complex process involving growth arrest, exit from the cell cycle, and expression of differentiated cell-type-specific functions. To identify small molecules promoting this process, a chemical library was screened by using a myeloid leukemic cell line that retained the potential to differentiate in culture. In the presence of a purine derivative, aminopurvalanol (AP), cells acquired phenotypic characteristics of differentiated macrophages and became arrested in the cell cycle with a 4N DNA content. AP also inhibited mitosis in Xenopus egg extracts, suggesting that it acted on an evolutionarily conserved cell cycle regulatory pathway. Affinity chromatography and biochemical reconstitution experiments with Xenopus egg extracts identified cyclin-dependent kinase (CDK) 1-cyclin B as a target of the compound. Although AP potently inhibited immunoprecipitates of both human CDK1 and CDK2 from human leukemic cell extracts, our results indicate that the compound preferentially targets the G2/M-phase transition in vivo.
Insights
Aminopurvalanol (AP) is a purine derivative that promotes cellular differentiation and cell cycle arrest. This compound targets cyclin-dependent kinase 1-cyclin B, impacting the G2/M phase transition.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cellular differentiation involves growth arrest and cell-type-specific functions.
- Identifying small molecules that promote differentiation is crucial for understanding cell cycle regulation.
Purpose of the Study:
- To screen a chemical library for small molecules that induce cellular differentiation.
- To identify the molecular target of the identified compound, aminopurvalanol (AP).
Main Methods:
- Screening of a chemical library using a myeloid leukemic cell line.
- Affinity chromatography and biochemical reconstitution experiments with Xenopus egg extracts.
- Inhibition assays using human leukemic cell extracts.
Main Results:
- Aminopurvalanol (AP) induced differentiation and cell cycle arrest (4N DNA content) in myeloid leukemic cells.
- AP inhibited mitosis in Xenopus egg extracts, indicating a conserved regulatory pathway.
- AP was identified as an inhibitor of cyclin-dependent kinase (CDK) 1-cyclin B, preferentially targeting the G2/M phase transition.
Conclusions:
- Aminopurvalanol (AP) is a novel small molecule that promotes cellular differentiation and G2/M cell cycle arrest.
- The compound's target is the CDK1-cyclin B complex, highlighting its role in cell cycle regulation.
- AP offers a potential tool for investigating cell cycle control and differentiation pathways.